scispace - formally typeset
D

Daniel C. Edelman

Researcher at University of Maryland, Baltimore

Publications -  14
Citations -  513

Daniel C. Edelman is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Hepatitis & Seroconversion. The author has an hindex of 8, co-authored 14 publications receiving 489 citations. Previous affiliations of Daniel C. Edelman include University of Maryland, College Park.

Papers
More filters
Journal ArticleDOI

Lowering the detection limits of HIV-1 viral load using real-time immuno-PCR for HIV-1 p24 antigen.

TL;DR: Data is shown that indicate real-time immuno-polymerase chain reaction (IPCR), a combination of the ELISA and PCR techniques, is more sensitive for HIV-1 p24 antigen detection than other currently reported methods.
Journal ArticleDOI

Human herpesvirus 8 – A novel human pathogen

TL;DR: This novel herpesvirus has and continues to present challenges to define its scope of involvement in human disease, and aspects of HHV-8 infection are discussed, such as, the human immune response, viral pathogenesis and transmission, viral disease entities, and the virus's epidemiology with an emphasis on HHv-8 diagnostics.
Journal ArticleDOI

Detection of ultra-low levels of pathologic prion protein in scrapie infected hamster brain homogenates using real-time immuno-PCR☆

TL;DR: The immuno-polymerase chain reaction (IPCR), a technique whereby the exponential amplification ability of PCR is coupled to the detection of proteins by antibodies in an ELISA format, was applied in a modified real-time IPCR method to detect ultra-low levels of prion protein.
Journal ArticleDOI

Detection of Kaposi's sarcoma-associated herpesvirus in oral and genital secretions of Zimbabwean women.

TL;DR: Data suggest that Kaposi's sarcoma-associated herpesvirus replicates in preferred anatomic sites at levels independent of PBMC viremia, and detection of genital-tract KSHV only among relatively immunosuppressed women may provide an explanation for infrequent perinatal transmission of the virus.
Journal ArticleDOI

Assessment of the performance of a rapid, lateral flow assay for the detection of antibodies to HIV.

TL;DR: This rapid, lateral flow, HIV-1/2/O assay was evaluated and was found to be better than most FDA-licensed enzyme-linked immunosorbent assays (ELISAs), detecting infection at the same time as the most sensitive ELISA in two of five seroconversion panels, and at theSame time or earlier than four of five ELISAs in all five panels.